Biomarker for Mannosidosis Disease (BioMannosidosis)
NCT03264040 · Status: WITHDRAWN · Type: OBSERVATIONAL
Last updated 2023-02-13
Summary
Development of a new MS-based biomarker for the early and sensitive diagnosis of Mannosidosis disease from blood (plasma)
Conditions
- Alpha-Mannosidase B Deficiency
- Lysosomal Alpha B Mannosidosis
- Alpha-Mannosidase Deficiency
Sponsors & Collaborators
-
CENTOGENE GmbH Rostock
lead INDUSTRY
Principal Investigators
-
Peter Bauer, Prof. · Centogene GmbH
Eligibility
- Min Age
- 2 Months
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2018-08-20
- Primary Completion
- 2021-02-28
- Completion
- 2021-02-28
Countries
- Germany
- India
- Sri Lanka
Study Locations
More Related Trials
-
Safety/Tolerability/Pharmacokinetic (PK)/Pharmacodynamics (PD) Study of BMN701 in Patients With Late-Onset Pompe Disease
NCT01230801 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Longitudinal Studies of the Glycoproteinoses
NCT01891422 ·Status: COMPLETED
-
Carotid Structure and Function in MPS Syndromes: A Multicenter Study of the Lysosomal Disease Network
NCT01586871 ·Status: COMPLETED
-
Natural History Study Protocol in PMM2-CDG (CDG-Ia)
NCT03173300 ·Status: ACTIVE_NOT_RECRUITING
-
Longitudinal Study of Bone Disease in Children with Mucopolysaccharidoses (MPS) I, II, and VI
NCT01521429 ·Status: COMPLETED
-
Open Label Study of mRNA-3704 in Patients With Isolated Methylmalonic Acidemia
NCT03810690 ·Status: WITHDRAWN ·Phase: PHASE1/PHASE2
-
Evaluation of Biochemical Markers and Clinical Investigation of Niemann-Pick Disease, Type C
NCT00344331 ·Status: RECRUITING
-
Study to Detect Unrecognized Mucopolysaccharidosis in Children Visiting Rheumatology, Hand or Skeletal Dysplasia Clinics
NCT01675674 ·Status: TERMINATED
-
An Open-Label Study to Assess the Safety & Efficacy of Leniolisib in Japanese Patients With APDS
NCT06249997 ·Status: RECRUITING ·Phase: PHASE3
-
Diagnosis of Mucopolysaccharidosis Disorders in Patients Presenting With Bilateral Hip Disease
NCT01707433 ·Status: COMPLETED
-
"The MaP Study": Mapping the Patient Journey in MMA and PA
NCT03484767 ·Status: COMPLETED
-
A Retrospective Chart Review of Deceased Patients With Mucopolysaccharidosis Type IIIB
NCT02293382 ·Status: COMPLETED
-
Natural History Study to Characterise the Course of Disease Progression in Participants With Mucopolysaccharidosis Type IIIB
NCT02293408 ·Status: TERMINATED
-
Mucopolysaccharidosis (MPS) VI Clinical Surveillance Program (CSP)
NCT00214773 ·Status: COMPLETED
-
A Study of Mucopolysaccharidosis Type IIIB (MPS IIIB)
NCT02493998 ·Status: COMPLETED
-
New Imaging Technology to Assess Effect of Enzyme Replacment Therapy on Eye Disease Progession in Mucopolysacchardiosis
NCT02583152 ·Status: UNKNOWN
-
A Phase 4 Two Dose Level Study of Naglazyme(TM) (Galsulfase) in Infants With MPS VI
NCT00299000 ·Status: COMPLETED ·Phase: PHASE4
-
Characterization of the Patient Population With Galactosialidosis
NCT01416467 ·Status: COMPLETED
-
A Study to Improve the Awareness of Mucopolysaccharidosis Type II in Brazil
NCT05155488 ·Status: COMPLETED
-
Complement Activation in the Lysosomal Storage Disorders
NCT04189601 ·Status: WITHDRAWN
-
Screening Protocol to Evaluate Acid Alpha-Glucosidase (GAA) Activity and GAA Gene Mutations in Patients With Late Onset Pompe Disease
NCT00113035 ·Status: COMPLETED
-
A Screening Study Evaluating Disease Status of Gaucher Type I Patients
NCT00795197 ·Status: WITHDRAWN
-
A Retrospective Natural History Study of Patients With Lysosomal Acid Lipase Deficiency/Wolman Phenotype
NCT01358370 ·Status: COMPLETED
-
A Prospective, Observational Study in Patients With Late-Onset Pompe Disease
NCT00077662 ·Status: COMPLETED
-
Biomarkers for Hunter Syndrome
NCT01330277 ·Status: TERMINATED